Riskpilot← Back to searchSign inGet full accessDESITIN PHARMA A/S
A/SActiveCVR 19389006Rådhuspladsen 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19961 employees
Revenue 2025
DKK 2,2M
+1% vs 2024
EBITDA margin
16.9%
-4% vs 2024
Equity ratio
91.3%
Financial strength
Net profit 2025
DKK 289K
+1% vs 2024
| Revenue | DKK 2,2M | +1% |
| EBITDA | DKK 364K | -4% |
| Net profit | DKK 289K | +1% |
| Total assets | DKK 7,7M | +7% |
| Equity | DKK 7M | +4% |
| Employees | 1 | — |
Legal name
DESITIN PHARMA A/S
CVR number
19389006
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 1996
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at markedsføre samt formidle salg af lægemidler samt hermed beslægtet virksomhed.
Address
Rådhuspladsen 16
Phone
+4533730073
Email
desitin@desitin.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.109 | 881 | 958 | 7.412 | 5.604 | 4.596 | 6.012 | 5.696 | 4.230 | 3.788 | 3.470 | 3.043 | 2.123 | 2.152 |
| Staff expenses | -456 | -570 | -559 | -4.179 | -3.991 | -3.677 | -3.974 | -4.897 | -3.616 | -3.305 | -2.955 | -2.579 | -1.744 | -1.788 |
| EBITDA | 485 | 311 | 399 | 3.233 | 1.613 | 919 | 2.038 | 799 | 614 | 483 | 515 | 465 | 379 | 364 |
| Depreciation & amort. | -2 | -5 | -6 | -11 | -15 | -15 | -20 | -36 | -13 | -15 | -15 | -15 | -16 | -0 |
| EBIT | 483 | 306 | 393 | 3.222 | 1.598 | 904 | 2.019 | 763 | 601 | 468 | 500 | 450 | 363 | 364 |
| Net financials | 2 | -11 | -3 | -30 | -6 | -33 | -26 | -27 | -45 | -13 | -27 | 867 | 8 | 4 |
| Profit before tax | 486 | 295 | 390 | 3.192 | 1.592 | 871 | 1.993 | 735 | 556 | 455 | 473 | 1.317 | 371 | 368 |
| Tax | 122 | 86 | 103 | 830 | 403 | 241 | 477 | 195 | 126 | 102 | 127 | -1.289 | 86 | 80 |
| Net profit | 363 | 209 | 287 | 2.362 | 1.189 | 630 | 1.516 | 541 | 430 | 353 | 346 | 2.606 | 286 | 289 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.061 | 543 | 526 | 5.428 | 4.872 | 4.511 | 6.647 | 7.287 | 7.647 | 7.364 | 6.956 | 9.818 | 7.205 | 7.712 |
| Equity | 783 | 342 | 379 | 3.684 | 3.723 | 3.603 | 5.118 | 5.659 | 6.089 | 6.442 | 6.413 | 8.645 | 6.755 | 7.044 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 277 | 201 | 147 | 1.742 | 1.148 | 908 | 1.529 | 1.628 | 1.558 | 922 | 542 | 1.173 | 450 | 668 |
| Total debt | 277 | 201 | 147 | 1.742 | 1.148 | 908 | 1.529 | 1.628 | 1.558 | 922 | 542 | 1.173 | 450 | 668 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20122025
Equity ratio
91.3%
This company
38.2%
Market median
+139% vs market
20122025
Return on equity
4.1%
This company
18.4%
Market median
-78% vs market
20122025
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
20122025
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20122025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EL Management | Management | 2020 | — | — |
HT Management | Management | 1996 | — | — |
AA Management | Management | 2019 | — | — |
TN Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
SL Management | Management | 2001 | — | — |
DA Founder | Founder | 1996 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2001 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 1996 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 1996 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DESITIN PHARMA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eli Lønne | Management | 0 companies |
| Hans-Jurgen Tacke | Management | 0 companies |
| Alexander Arnkværn Berg | Management | 0 companies |
| Tina Nørgaard | Chief Executive Officer | 0 companies |
| Søren Lars Mikkelsen | Management | 0 companies |
| Desitin Arzneimittel GmbH | Founder | 0 companies |
| Christoph Steinschulte | Board of Directors | 0 companies |
| Michael Hanke | Board of Directors | 0 companies |
| Martin Schütt | Chairman | 0 companies |
| Katrin Elisabeth Thieken | Board of Directors | 0 companies |
| Christian Eric Schmolck | Board of Directors | 0 companies |
| Philipp Andreas Bloching | Chairman | 0 companies |
| Dieter Heinrich Peitz | Chairman | 0 companies |